Lumify Interactions
There are 366 drugs known to interact with Lumify (brimonidine ophthalmic), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 366 are moderate.
- View all 366 medications that may interact with Lumify
- View Lumify alcohol/food interactions (1)
- View Lumify disease interactions (3)
Most frequently checked interactions
View interaction reports for Lumify (brimonidine ophthalmic) and the medicines listed below.
- albuterol
- Allegra (fexofenadine)
- amoxicillin
- aspirin
- atorvastatin
- azelastine nasal
- Benadryl (diphenhydramine)
- cetirizine
- CoQ10 (ubiquinone)
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydrochlorothiazide
- ibuprofen
- levothyroxine
- lisinopril
- loratadine
- losartan
- magnesium glycinate
- magnesium oxide
- montelukast
- multivitamin
- omeprazole
- pantoprazole
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Lumify alcohol/food interactions
There is 1 alcohol/food interaction with Lumify (brimonidine ophthalmic).
Lumify disease interactions
There are 3 disease interactions with Lumify (brimonidine ophthalmic) which include:
Report options
QR code containing a link to this page
More about Lumify (brimonidine ophthalmic)
- Lumify consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (171)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.